TAG: "Pharmacy"

UCSF, Walgreens open new pharmacy to explore models of patient-centered care

“Walgreens at UCSF” aims to improve medication use, reduce hospital readmissions.

UC San Francisco and Walgreens (NYSE: WAG) (Nasdaq: WAG) have opened a unique Walgreens store on the UCSF campus that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively by offering pharmacist-based patient care and expanded health and wellness services to the community.  A joint effort among Walgreens, the UCSF School of Pharmacy and UCSF Medical Center, “Walgreens at UCSF” also will explore new models for improving overall patient care.

“Walgreens at UCSF is an ideal environment for our pharmacists to work with UCSF Medical Center and School of Pharmacy faculty to further innovate in health care while providing greater access to services for the surrounding community,” said Joel Wright, Walgreens divisional vice president, specialty solutions group. “At Walgreens, we are very pleased to share and develop best practices with UCSF pharmacists and pharmacy students, which further our commitment to help people get, stay and live well.” Walgreens at UCSF, located across the street from UCSF Medical Center, is one of Walgreens “Well Experience” stores, which offer expanded health services and are designed to foster increased patient-pharmacist interaction. With an expanded pharmacy including multiple areas for private consultations, Walgreens and UCSF pharmacists and UCSF pharmacy students are more accessible to community members and patients.

Core clinical health services include medication counseling by a pharmacist as the standard of care and comprehensive medication reviews for customers who receive prescriptions. Pharmacists will work with patients to create and update accurate, portable medication lists to take to their appointments with medical providers. This approach can help decrease drug-drug interactions and encourage patient medication adherence.

“Modern medicine has transformed many diseases from urgent, life-threatening conditions into chronic illnesses that can be managed with the right medications, but that means more and more patients are juggling multiple prescriptions, with complex instructions,” said Joseph Guglielmo, Pharm.D., a leader in the field of clinical pharmacy and dean of the UCSF School of Pharmacy. “And, in many instances, this complicated medication list is inaccurate and incomplete. This collaboration aims to transform the practice of community pharmacies to enable pharmacists to do what they’re trained to do, which is helping patients manage their health with the right medications and understand how to take them correctly.”

The collaboration builds upon Walgreens’ leadership in pioneering new approaches to pharmacy care, as well as UCSF’s long history of collaboration in teaching, research and patient care between the School of Pharmacy and UCSF Medical Center, which together piloted the first hospital-based clinical pharmacy program in the nation, in the 1960s.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.


CATEGORY: NewsComments Off

New movement focuses on paradox of cigarette sales in pharmacies

UCSF scientists, major pharmacy launch national move to halt tobacco sales in drugstores.

Steven Schroeder, UC San Francisco

Pharmacies, focused on the health and well-being of their customers, have long been saddled with a paradox: they sell cigarettes and other tobacco products, even though tobacco use is the nation’s leading cause of preventable death.

If retailers, particularly pharmacies, were to discontinue selling cigarettes, fewer smokers and fewer deaths by smoking would occur, according to a new opinion article co-written by a UC San Francisco scientist. That’s also the premise behind a new decision by CVS Caremark, the nation’s largest pharmacy health care company, to end cigarette and tobacco sales in its stores this year.

In a Viewpoint article published online today (Feb. 5) in JAMA, the Journal of the American Medical Association, the authors say that selling tobacco products is “clearly antithetical” to the role of pharmacies, especially as pharmacies expand their role as an integral part of the nation’s health care system.

The JAMA Viewpoint is written by Troyen A. Brennan, M.D., M.P.H., executive vice president and chief medical officer of CVS Caremark; and Steven A. Schroeder, M.D., a UCSF professor and director of the Smoking Cessation Leadership Center.

Casting a harsh light on tobacco sales in drugstores, the authors say that selling tobacco products contradicts a commitment to health care.

The goal of the authors: eliminate tobacco sales in America’s drugstores.

“Nowhere else in health care are tobacco products available in the same setting where diseases are being diagnosed and treated,” they write.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Biases in animal studies may differ from those in clinical trials

UCSF analysis examines studies of statins.

Lisa Bero, UC San Francisco

Lisa Bero, UC San Francisco

A new analysis of animal studies on cholesterol-lowering statins by UC San Francisco researchers found that non-industry studies had results that favored the drugs even more than studies funded by industry.

The analysis of 63 animal studies of statins, led by Lisa Bero, Ph.D., UCSF professor clinical pharmacy, was published online Jan. 21 in the scientific journal PLoS Biology.

In previous studies, Bero determined that drug-company-sponsored clinical trials were associated with publication of outcomes that favor the sponsor. Bero’s work has been cited as part of policy reform efforts that have led many journal publishers, agencies and institutions to require researchers to disclose funding sources and possible conflicts of interest when presenting their research.

The impetus for the current study, Bero said, was to explore whether or not industry-funded animal studies also would be likely to yield more positive outcomes for the companies’ drug candidates.

But in their analysis the researchers found the opposite: Results of animal studies that had industry sponsorship were less likely to measure a benefit for statins in slowing or preventing arterial disease. Of the studies that disclosed funding, 9 of 19 industry-sponsored studies had results that favored statins, in comparison to 18 out of 28 studies that favored statins among studies not funded by industry.

Read more

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

Brave new world

UCSF pharmacy school one of nation’s first to offer students genetic testing for drug response.

Brave new world illustrationWhen Julia Choi’s grandmother suffered her third stroke, a doctor in the emergency room gave her blood thinner medication to prevent another stroke. Not long after, Choi’s grandmother experienced gastrointestinal bleeding – a common side effect of blood thinners. She later passed away. Choi never found out if the bleeding was indeed caused by the drug or by something else.

The memories of her grandmother’s struggle came flooding back to Choi last spring when she took a course in genetics and drug response as a first-year pharmacy student at UC San Francisco. Not only did she learn that some people carry variants in their genes that cause adverse reactions to clopidogrel, the drug her grandmother had been given, but Choi also had the opportunity to have her own genes tested for such mutations.

The UCSF School of Pharmacy is one of the first pharmacy schools in the nation to offer its students genetic testing for drug response. It’s just one way UCSF is educating students about precision medicine – an emerging approach that collects and integrates vast amounts of data and new technologies to develop individualized treatments. As the health care providers of the future, today’s students will be diagnosing and treating patients based on a barrage of information not just about the person in front of them, but also about millions of other patients around the world.

UCSF pharmacy student Julia Choi received genetic testing in one of her courses, an experience that she says was intensely personal – and important training for her future as a pharmacist.

UCSF pharmacy student Julia Choi received genetic testing in one of her courses, an experience that she says was intensely personal – and important training for her future as a pharmacist.

Genetic codes; environmental and nutritional data; reports from patients’ electronic health care monitors; and input from epidemiologists, informaticians and scientists studying the molecular underpinnings of disease – all these factors must be considered in the world of precision medicine. The upside is that “we will be able to find the right treatment for our patients, without going through all the trial and error we do today,” says Catherine Lucey, M.D., a resident alumna and the vice dean for education at UCSF School of Medicine.

“What’s so great about being at UCSF is that we’re fortunate enough to have people who strive to practice tomorrow’s medicine today,” she continues. The university has been educating its students regarding precision medicine for years by teaching them about genetics, population-based clinical research, and the nature and importance of working in multidisciplinary teams.

As Choi learned firsthand in the School of Pharmacy’s Genetics and Pharmacogenetics course, a single gene can influence drug response – knowledge that is shaping more precise approaches to therapeutics.

She was one of 22 out of 122 students in her class to opt in for the genetic testing, which evaluated the CYP2C19 enzyme. People who have variants of this enzyme can over- or under-metabolize clopidogrel (also known by the brand name Plavix), which means they are 3.6 times more likely to suffer a heart attack, stroke, or even death. These outcomes can be easily avoided, however, by first testing a patient for the genetic mutations and then prescribing a higher or lower dose of the drug or another drug entirely.

Read more

Related link:
UCSF Magazine

For more health news, visit UC Health, subscribe by email or follow us on Flipboard.

CATEGORY: NewsComments Off

UCSF names vice provost for academic affairs

Clinician-educator-researcher Brian Alldredge to start in new position Nov. 1.

Brian Alldredge, UC San Francisco

Brian Alldredge, UC San Francisco

Brian Alldredge, Pharm.D., associate dean for the UCSF School of Pharmacy for the past 12 years and a member of the faculty for 28 years, has been named vice provost for academic affairs, effective Nov. 1.

Alldredge is a clinician-educator-researcher with research and clinical interests in epilepsy, seizure emergencies, pharmacogenomics and pharmacy education. He holds a joint appointment as a professor of clinical pharmacy in the School of Pharmacy and a clinical professor in the Department of Neurology in the School of Medicine.

In his new role, Alldredge will report directly to Jeffrey Bluestone, Ph.D., executive vice chancellor and provost (EVCP). He will be part of the EVCP leadership team, overseeing all aspects of faculty and academic affairs, including the Chancellor’s Council on Faculty Life, faculty development and advancement programs and initiatives, and supporting the EVCP and chancellor in all their strategic and operational goals related to faculty and academics.

“The role of vice provost, academic affairs, is critical to the well-being and productivity of faculty, and I am pleased that Brian will be taking this on,” Bluestone said. “Brian brings both highly relevant professional experience and a deep personal passion for the issues that arise in faculty affairs.”

Read more

CATEGORY: NewsComments Off

New health professionals need consistent pain management education

Basic skills in pain management sought across education programs for clinicians.

Scott Fishman, UC Davis

More Americans are coping with chronic pain than ever before. Yet clinicians’ understanding of pain and their pain management skills vary widely because no such educational framework exists. Following an Institute of Medicine (IOM) recommendation, two UC Davis researchers led a team of experts to develop expectations for consistent, comprehensive pain management education for new health professionals, including nurses, physicians, pharmacists and physical therapists.

In an article scheduled for publication in the July issue of Pain Medicine, “Core Competencies for Pain Management: Results of an Interprofessional Consensus Summit” (available for free, public download at www.ucdmc.ucdavis.edu/paineducation/Happenings/PainMedicineArticle2013.pdf), UC Davis experts Scott Fishman and Heather M. Young, along with a team of international experts representing various health professions, identify the desired skills and knowledge new health professionals must possess to best care for people with pain. These educational outcomes, known as core competencies, serve as a foundation for the development of comprehensive pain management curricula for early learners in the health professions.

Heather Young, UC Davis

“The current state of educational content for pain management in schools of medicine and nursing, as well as other health professions, is often inadequate,” Fishman said. “The creation, distribution, and ultimately, the adoption of these basic expectations for pain management education is a critical step toward the preparation of more health care professionals who understand and have basic skills to safely and effectively address pain.”

The 2011 IOM report revealed the need for improved pain education for health professionals due to increasing numbers of Americans coping with chronic pain, as well as skyrocketing costs associated with chronic pain. According to the IOM, an estimated 100 million American adults — more than the total affected by heart diseases, cancer and diabetes combined — suffer from chronic pain. Pain costs the nation up to $600 billion annually in medical treatment and lost productivity.

Read more

CATEGORY: NewsComments Off

UCSF names chair of the Department of Clinical Pharmacy

Lisa Kroon to lead the department.

Lisa Kroon, UC San Francisco

Lisa Kroon, Pharm.D., has been named the new chair of the Department of Clinical Pharmacy within the UC San Francisco School of Pharmacy, effective July 1.

Kroon has served as interim chair of the department since July 2012, when the previous chair, B. Joseph Guglielmo, Pharm.D., became interim dean and later dean of the School of Pharmacy.

“The leadership of both the Department of Clinical Pharmacy and the UCSF Medical Center’s Department of Pharmaceutical Services unanimously supported Lisa’s selection,” Guglielmo said. “We are fortunate to have such an accomplished, even-keeled department chair.”

The UCSF School of Pharmacy has the nation’s top-ranked Doctor of Pharmacy degree program, according to U.S. News & World Report, and tops the list for research funding from the National Institutes of Health.

Kroon said the purpose of her department’s work in research, education, and patient care “is to advance the safe and effective use of therapeutics to improve health.”

“The Affordable Care Act has opened a lot of eyes to what quality care can be, how it can be provided, and by whom,” she said. “We’re building the evidence for new ways for pharmacists to improve patient health – and even to lower costs – and to prepare students for what is truly a new day in pharmacy practice.”

The UCSF Medical Center is a close collaborator. Kroon adds, “It’s a potent combination with the potential to improve medication use, safety and effectiveness in patient care settings – inside and outside the hospital – in bold new ways we can’t even imagine today.”

Read more

CATEGORY: NewsComments Off

Study IDs protein essential for normal heart function

Protein being studied to fight cancer; may cause toxicity in cardiac cells.

Asa Gustafsson, UC San Diego

A study by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology at UC San Diego, shows that a protein called MCL-1, which promotes cell survival, is essential for normal heart function.

Their study, published in the June 15 online issue of the journal Genes & Development, found that deletion of the gene encoding MCL-1 in adult mouse hearts led to rapid heart failure within two weeks, and death within a month.

MCL-1 (myeloid cell leukemia-1) is an anti-apoptotic protein, meaning that it prevents or delays the death of a cell. It is also a member of the BCL-2 family of proteins that regulate mitochondria – the cell’s power producers – and cell death. Aberrant expression of anti-apoptotic BCL-2 family members is one of the defining features of cancer cells, and is strongly associated with resistance to current therapies. Thus, these proteins are currently major targets in the development of new therapies for patients with cancer.

But, while MCL-1 is up regulated in a number of human cancers, contributing to the overgrowth of cancer cells, it is found at high levels in normal heart tissue. Additionally, the researchers found that autophagy – a process which deals with mitochondrial maintenance and is normally induced by myocardial stress – was impaired in mice with MCL-1 deficient hearts.

In summary, the study demonstrated that the loss of MCL-1 led to rapid dysfunction of mitochondria, impaired autophagy and heart failure, even in the absence of cardiac stress.

“Cardiac injury, such as a heart attack, causes levels of MCL-1 to drop in the heart, and this process may increase cardiac cell death,” said Åsa B. Gustafsson, Ph.D., an associate professor at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences. “Therefore, preserving normal levels of this protein in cardiac tissue could reduce damage after a heart attack and prevent progression to heart failure.”

Read more

CATEGORY: NewsComments Off

Health professions education growing in new directions, UC report finds

Enrollment has increased significantly in medicine, nursing, pharmacy and public health.

Click image to download report

>>Download report

The University of California has issued a report that highlights some of the recent trends associated with the rapid growth in health professional schools and enrollment.

Enrollment in U.S. health professional schools has increased significantly in medicine, nursing, pharmacy and public health, according to the report, “A New Era of Growth: A Closer Look at Recent Trends in Health Professions Education.” For example, there has been unprecedented growth in total U.S. pharmacy student enrollment through expansion of existing programs and the establishment of new schools. Since 2005 alone, the number of accredited pharmacy schools has risen 48 percent (87 to 129).

The total enrollment and number of new U.S. medical schools also has increased. More striking, however, has been the rapid growth in the number of for-profit international medical schools located in the Caribbean and seeking to attract U.S. students. Growth has been more moderate in dentistry, optometry and veterinary medicine.

The report describes some of the changes in health professions education since 2007, when UC issued “A Compelling Case for Growth,” an in-depth review of health workforce needs as part of a systemwide planning effort that helped pave the way for enrollment growth at all five of UC’s longstanding medical schools, establishment of a new nursing school at UC Davis, and the recent accreditation and establishment of UC’s sixth school of medicine at UC Riverside.

The new report reviews the seven fields in which UC has health professional schools. The report also identifies trends and provides information by profession about the number of schools and enrollment in California and nationally. Information regarding current tuition levels by institution also is included.

“As the nation’s largest health sciences instructional program, UC has an important role to play in informing the public about the state of health professions education,” said Dr. Cathryn Nation, UC associate vice president for health sciences. “The ‘New Era of Growth’ report provides a valuable snapshot of trends that deserve our attention and further discussion.”

Trends identified in the report include:

  • Rapid growth in educational programs and total enrollment. Since 2007, the number of U.S. schools in the seven health professions surveyed has grown by 48 percent (865 to 1,283). As a result, enrollment has increased by 34 percent (252,484 to 339,107), with the majority of this growth taking place primarily in medicine, nursing, pharmacy and public health.
  • Development of new programs and business models. For-profit schools and programs have proliferated, both in the U.S. and the Caribbean, where 22 of the 61 medical schools admitted their first classes in the past decade. Non-research institutions have added new schools of pharmacy and dentistry. Accelerated and alternate-entry programs have grown, particularly in nursing. Professional doctorates have increased, as have programs that deliver education online, with growth in online public health programs.
  • Rising student costs and indebtedness. Between 2005 and 2010, UC medical schools experienced a nearly 50 percent increase, on average, in the four-year cost of attendance. Not surprisingly, student debt also is rising. Viewed over a longer period, the increase is even more dramatic. The total cost of attendance has increased for all UC professional degree programs, posing new challenges for students interested in pursuing careers in public service. For example, the average educational debt of veterinary medicine graduates (excluding undergraduate loans) at UC Davis nearly quadrupled from $29,770 in 1993 to $118,772 in 2011.

Recent growth at UC

Across the UC system, relatively modest, planned enrollment growth in medical student enrollment has occurred over the past decade. This has occurred through new UC Programs in Medical Education (PRIME) that focus on the needs of medically underserved communities. Through this special initiative, UC boosted total medical student enrollment by approximately 350 students across the UC system. However, most of this growth, and most that is occurring in nursing, has been unfunded by the state. Major multiyear budget cuts and a lack of state funding also contributed to a delay in the opening of UC Riverside’s new school of medicine, which will welcome its first class of 50 students in fall 2013.

Looking toward the future

Notwithstanding the growth in enrollment and establishment of new schools across the U.S., workforce shortages persist in many health professions, including medicine, public health and others — needs that will increase dramatically as provisions of health care reform take effect. The balance is currently shifting for some professions. In pharmacy, for instance, the profession has experienced such rapid growth in recent years that some estimates suggest a total national supply of pharmacists that may outpace future demand. Amid these many changes, it will be important to monitor the impact that the new schools and programs make, with particular attention to issues of quality, cost and student success, according to the report.

“As the higher education community plans for the future, the importance of maintaining educational quality, improving access and affordability for students, and improving access and health outcomes for patients are among the central goals that must remain in focus,” the report states.

About UC Health
University of California Health includes five academic health centers with 10 hospitals and 18 health professional schools and programs on seven UC campuses — UC Berkeley, UC Davis, UC Irvine, UCLA, UC Riverside, UC San Diego and UC San Francisco. For more information, visit http://health.universityofcalifornia.edu.

CATEGORY: Issues, SpotlightComments Off

New center targets ocean contaminants and human health

Scripps scientists lead two projects to track potentially toxic chemicals in marine life, impacts on human health.

(From left) Paul Jensen, Brad Moore, Eric Allen, Lihini Aluwihare of Scripps and Eunha Hoh of San Diego State University.

Capitalizing on UC San Diego’s unique ability to address environmental threats to public health, a new center based at Scripps Institution of Oceanography at UC San Diego will target emerging contaminants found naturally in common seafood dishes as well as man-made chemicals that accumulate in human breast milk.

With $6 million in joint funding from the National Institutes of Health and the National Science Foundation, the new Scripps Center for Oceans and Human Health will track natural chemicals known as halogenated organic compounds, or HOCs. Human-manufactured varieties include polybrominated diphenyl ethers, or PBDEs, chemicals that until recently were manufactured and broadly used in commercial products as flame retardants in the textile and electronics sectors.

Less is known about the natural versions of HOCs that accumulate in marine mammals such as seals and dolphins and have been identified in top predators that humans consume such as tuna and swordfish. While PBDEs are well known for their toxicity and have been linked to a variety of human diseases, including cancer and thyroid ailments, the origin and transmission of their natural counterparts are poorly understood.

The Scripps Center for Oceans and Human Health will investigate the biology and chemistry behind these natural contaminants in the Southern California Bight, from Point Conception in Santa Barbara south to Ensenada, Mexico.

“The new Center for Oceans and Human Health is uniting leading experts in oceanography and medicine, two areas that make UC San Diego one of the best and most unique universities in the world, to address an emerging threat to public health and safety,” said UC San Diego Chancellor Pradeep K. Khosla. “UC San Diego is proud to be leading this effort in collaboration with other prominent institutions around the San Diego region.”

“The Scripps Center for Oceans and Human Health is focused on addressing to what extent nature contributes to the production and transmission of these toxins in the marine environment,” said Bradley Moore, director of the new center and a professor of oceanography and pharmaceutical sciences at Scripps and the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. “Southern California waters will be the focus of our study, in part because our state has the highest reported incidence of polybrominated chemicals in human breast milk in the world.”

Read more

CATEGORY: NewsComments Off

“Sam” Skaggs dies at 89

UC San Diego pharmacy school benefactor “a pioneer, a visionary.”

L.S. "Sam" Skaggs

L.S. “Sam” Skaggs, whose enduring support of pharmacy education and research helped fuel the growth and development of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, died Thursday at the age of 89 of causes related to age.

Skaggs built a retail food-and-drug business empire, but the Utah businessman also nurtured a decades-long, widespread interest in promoting the health sciences. In 2004, he and his family’s Institute for Research donated $30 million to UC San Diego’s then-2-year-old School of Pharmacy and Pharmaceutical Sciences. It was the largest gift to UC San Diego Health Sciences at the time, and among the largest in UC San Diego history.

“Sam Skaggs was a pioneer, a visionary and a generous philanthropist,” said Chancellor Pradeep K. Khosla. “He helped ensure the success of the School of Pharmacy and Pharmaceutical Sciences. His legacy lives on through his contributions and dedication to the future of pharmaceutical care. We will always be grateful for the positive impact he’s had on the health and well-being of our campus and community.”

The Skaggs School of Pharmacy and Pharmaceutical Sciences, named in Sam Skaggs’ honor, is one of just two pharmacy schools in the UC system and a national leader in pharmaceutical education and research. It boasts more than 150 salaried and volunteer faculty members, with a current enrollment of 240 Pharm.D. and 60 Ph.D. students as well as 30 pharmacy residents.

“Sam Skaggs was instrumental in the development of our school,” said Palmer Taylor, Ph.D., dean of the Skaggs School and associate vice chancellor of health sciences at UC San Diego. “From our humble beginnings in a temporary building, he followed our growth, occasionally offering sage advice. His gift in 2004 was transformational. It gave us the resources and flexibility to not just grow, but excel.”

Skaggs, who resided in Salt Lake City, built his business and fortune growing the Payless Drug Stores chain, which he took over after his father died from a stroke in 1950. He was 26. In 1979, he acquired American Stores, creating the second-largest U.S. food retailer in the United States. In 1995, shortly before he retired, Skaggs headed one of the largest food companies in the world, with 1,700 stores in 26 states and annual revenue exceeding $22 billion.

A significant portion of his wealth was devoted to diverse philanthropic interests, from pharmaceutical education and research throughout the American west to religious interests, which included support of Mater Dei Catholic High School in Chula Vista.

Memorial contributions may be made to the “Skaggs School of Pharmacy Scholarship Fund.” Checks payable to the UC San Diego Foundation can be sent to University of California, San Diego, c/o Andrina Marshall, 9500 Gilman Drive #0657, La Jolla, CA 92093-0657; donations also can be made online at www.givetoucsd.ucsd.edu. Please type “Skaggs School of Pharmacy Scholarship Fund” in the keyword search section.

View original article

CATEGORY: NewsComments Off

UCSF appoints new dean of nation’s top pharmacy school

Pharmacist Joe Guglielmo to lead school.

B. Joseph Guglielmo, UC San Francisco

UC San Francisco has named a highly accomplished pharmacist and clinical scientist, B. Joseph Guglielmo, Pharm.D., to lead the nation’s premier School of Pharmacy, continuing the school’s focus on shaping the course of the therapeutic sciences, pharmacy education, patient care, and health policy.

UCSF Chancellor Susan Desmond-Hellmann, M.D., M.P.H., announced the appointment today, noting the numerous contributions that Guglielmo already has made to UCSF, as well as his breadth of leadership across the academic pharmacy landscape.

“In its decades as the pre-eminent School of Pharmacy in the nation, the school has never been stronger, and there is no better dean to guide it into the future,” Desmond-Hellmann said. “Joe is both an able leader and an international expert in his field, and will provide a clear course for the school as it helps guide the changing world of health care.”

As the nation’s leading pharmacy school in terms of both research funding from the National Institutes of Health and the ranking of its Doctor of Pharmacy degree program in U.S. News & World Report, the UCSF School of Pharmacy serves as a bellwether for pharmacy schools worldwide.

“It is a tremendous honor to be named the next steward of this accomplished school,” said Guglielmo. “The caliber of people and the culture of respect and inclusion here are second to none: the faculty is brilliant and collegial; the students are leaders by instinct and experience; and the staff is extremely talented. Excellence is their common ground.”

Guglielmo has served as the school’s interim dean since July 2012. He previously led the school’s Department of Clinical Pharmacy as the Thomas A. Oliver Chair in Clinical Pharmacy.

“We see a time when new, precise therapeutics – drugs, medical devices, and diagnostic tests – are used safely and effectively to improve the health of people everywhere,” he said. “This view will drive my work as dean.”

Read more

CATEGORY: NewsComments Off

Fresno Bee: UCSF Fresno pediatric residency program

Click video for closed captions, larger view

Connect with UC

UC for California   Follow UC News on Twitter   Follow UC on Facebook   Subscribe to UC Health RSS feed

Facebook leads to lifesaving surgery at UC San Diego

Click video for closed captions, larger view


We welcome your ideas and feedback. To subscribe or send comments or suggestions, please email alec.rosenberg@ucop.edu.